Skip to main content

Animations

MJFF Publications

2531 - 2540 of 6466 Results
Title
Year
  • Year
  • 2016
  • 2014
  • 2026
  • 2018
  • 2026
  • 2015
  • 2020
  • 2019
  • 2025
  • 2017
  • LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies
    2016
    Summary Details
    OPEN
    Title: LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26892
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.05.012
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Excess risk of fracture in incident Parkinson’s disease Medicare beneficiaries
    Journal Name: Injury Epidemiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1186/s40621-025-00643-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.01.015
    Citation Count: 177
  • Summary Details
    OPEN
    Title: DAT-SPECT-based subtype and stage inference in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-026-01347-2
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Feasibility of Virtual Research Visits in Fox Trial Finder
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa
    DOI - Digital Object Identifier: 10.3233/jpd-150549
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Genetic Testing for Parkinson Disease
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831
    Citation Count: 39
  • Summary Details
    OPEN
    Title: The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital age
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27673
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Beyond Alzheimer’s disease—translating biomarker insights across CNS diseases
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.adr2511
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20170802
    Citation Count: 166
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.